ELI LILLY & Co (LLY) operating KPIs
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1417.54+43.84 (+3.19%)
Close on Oct 30, 2026Market cap $1.33TP/E 46.0Yield 0.44%
Eli Lilly elanco Animal Health segment — Revenue ($M) [legacy segment spun off March 2019] ($M)
Form 10-K Segment Reporting Note (prior to Elanco spin-off in Q1 2019)
Latest, Q3 2018
773
Period ended Sep 30, 2018
Change on a year earlier
+4.3%
741 in Q3 2017
History
23 quarters
Since Q2 2012
Sources
18
Documents cited below
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Elanco Animal Health segment — Revenue ($M) [legacy segment spun off March 2019] ($M) | Year on year | Source |
|---|---|---|---|---|
| Q3 2018 | Sep 30, 2018 | 773 | +4.3% | Form 10-Q (filed 2018-11-06) ↗ |
| Q2 2018 | Jun 30, 2018 | 792 | +0.9% | Form 10-Q (filed 2018-07-25) ↗ |
| Q1 2018 | Mar 31, 2018 | 761 | -1.1% | Form 10-Q (filed 2018-04-27) ↗ |
| Q4 2017 | Dec 31, 2017 | 791 | -5.6% | Form 10-K (filed 2018-02-20) ↗ |
| Q3 2017 | Sep 30, 2017 | 741 | +4.9% | Form 10-Q (filed 2017-10-27) ↗ |
| Q2 2017 | Jun 30, 2017 | 785 | -8.7% | Form 10-Q (filed 2017-07-28) ↗ |
| Q1 2017 | Mar 31, 2017 | 769 | +2.0% | Form 10-Q (filed 2017-05-01) ↗ |
| Q4 2016 | Dec 31, 2016 | 838 | +3.2% | Form 10-K (filed 2017-02-21) ↗ |
| Q3 2016 | Sep 30, 2016 | 706 | -9.3% | Form 10-Q (filed 2016-10-28) ↗ |
| Q2 2016 | Jun 30, 2016 | 860 | +2.3% | Form 10-Q (filed 2016-07-28) ↗ |
| Q1 2016 | Mar 31, 2016 | 755 | +0.6% | Form 10-Q (filed 2016-04-29) ↗ |
| Q4 2015 | Dec 31, 2015 | 812 | +28.2% | Form 10-K (filed 2016-02-19) ↗ |
| Q3 2015 | Sep 30, 2015 | 779 | +33.2% | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2015 | Jun 30, 2015 | 841 | +39.9% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2015 | Mar 31, 2015 | 750 | +42.2% | Form 10-Q (filed 2015-04-30) ↗ |
| Q4 2014 | Dec 31, 2014 | 633 | – | Form 10-Q (filed 2015-10-30) ↗ |
| Q3 2014 | Sep 30, 2014 | 585 | – | Form 10-Q (filed 2015-10-30) ↗ |
| Q2 2014 | Jun 30, 2014 | 601 | +10.6% | Form 10-Q (filed 2015-07-30) ↗ |
| Q1 2014 | Mar 31, 2014 | 527 | +5.7% | Form 10-Q (filed 2015-04-30) ↗ |
| Q2 2013 | Jun 30, 2013 | 544 | +6.1% | Form 10-Q (filed 2013-07-26) ↗ |
| Q1 2013 | Mar 31, 2013 | 499 | – | Form 10-Q (filed 2014-04-28) ↗ |
| Q3 2012 | Sep 30, 2012 | 479 | – | Form 10-Q (filed 2013-10-30) ↗ |
| Q2 2012 | Jun 30, 2012 | 512 | – | Form 10-Q (filed 2013-07-26) ↗ |
Breakdown
What makes up elanco animal health segment — revenue ($m) [legacy segment spun off march 2019]
Cite this data
StockData. (2026). Eli Lilly Elanco Animal Health segment — Revenue ($M) [legacy segment spun off March 2019] ($M), quarterly Q2 2012–Q3 2018 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/seg_animal_health_rev_legacy
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.